Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection

被引:33
作者
Gao, Yan-Lei [1 ]
Du, Yue [1 ]
Zhang, Chao [1 ]
Cheng, Cheng [1 ]
Yang, Hai-Yan [1 ]
Jin, Yue-Fei [1 ]
Duan, Guang-Cai [1 ]
Chen, Shuai-Yin [1 ]
机构
[1] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou, Henan, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2020年 / 13卷
关键词
renin angiotensin system; acute lung injury and acute respiratory distress syndrome; viral infection; II RECEPTOR BLOCKER; CONVERTING ENZYME-2; CORONAVIRUS; ACE2; EXPRESSION; SARS-COV-2; MORTALITY; COVID-19; SUSCEPTIBILITY; EPIDEMIOLOGY;
D O I
10.2147/IDR.S265718
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The renin-angiotensin system (RAS) is the most important regulatory system of electrolyte homeostasis and blood pressure and acts through angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/Ang II type 1 (AT1) receptor axis and angiotensin-converting enzyme 2 (ACE2)/angiotensin (1-7)/MAS receptor axis. RAS dysfunction is related to the occurrence and development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) and causes a serious prognosis and even death. ALI/ARDS can be induced by various ways, one of which is viral infections, such as SARS-CoV, SARS-CoV-2, H5N1, H7N9, and EV71. This article reviews the specific mechanism on how RAS dysfunction affects ALI/ARDs caused by viral infections. SARS-CoV and SARS-CoV-2 enter the host cells by binding with ACE2. H5N1 and H7N9 avian influenza viruses reduce the ACE2 level in the body, and EV71 increases Ang II concentration. Treatment with angiotensin-converting enzyme inhibitor and angiotensin AT1 receptor blocker can alleviate ALI/ARDS symptoms. This review provides suggestions for the treatment of lung injury caused by viral infections.
引用
收藏
页码:3715 / 3725
页数:11
相关论文
共 106 条
  • [21] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    [J]. CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [22] Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
    Gao, Hai-Nv
    Lu, Hong-Zhou
    Cao, Bin
    Du, Bin
    Shang, Hong
    Gan, Jian-He
    Lu, Shui-Hua
    Yang, Yi-Da
    Fang, Qiang
    Shen, Yin-Zhong
    Xi, Xiu-Ming
    Gu, Qin
    Zhou, Xian-Mei
    Qu, Hong-Ping
    Yan, Zheng
    Li, Fang-Ming
    Zhao, Wei
    Gao, Zhan-Cheng
    Wang, Guang-Fa
    Ruan, Ling-Xiang
    Wang, Wei-Hong
    Ye, Jun
    Cao, Hui-Fang
    Li, Xing-Wang
    Zhang, Wen-Hong
    Fang, Xu-Chen
    He, Jian
    Liang, Wei-Feng
    Xie, Juan
    Zeng, Mei
    Wu, Xian-Zheng
    Li, Jun
    Xia, Qi
    Jin, Zhao-Chen
    Chen, Qi
    Tang, Chao
    Zhang, Zhi-Yong
    Hou, Bao-Min
    Feng, Zhi-Xian
    Sheng, Ji-Fang
    Zhong, Nan-Shan
    Li, Lan-Juan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (24) : 2277 - 2285
  • [23] A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
    Grover, Abhinav
    Oberoi, Mansi
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (02) : 148 - 157
  • [24] Gu H, 2003, CHIN J DIALYSIS ARTI, V02, P1
  • [25] Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension A Meta-Analysis
    Guo, Xiaoming
    Zhu, Yueli
    Hong, Yuan
    [J]. HYPERTENSION, 2020, 76 (02) : E13 - E14
  • [26] Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats
    Hamming, I.
    van Goor, H.
    Turner, A. J.
    Rushworth, C. A.
    Michaud, A. A.
    Corvol, P.
    Navis, G.
    [J]. EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) : 631 - 638
  • [27] Henry Christopher, 2018, Proc (Bayl Univ Med Cent), V31, P419, DOI 10.1080/08998280.2018.1499293
  • [28] TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
    Heurich, Adeline
    Hofmann-Winkler, Heike
    Gierer, Stefanie
    Liepold, Thomas
    Jahn, Olaf
    Poehlmann, Stefan
    [J]. JOURNAL OF VIROLOGY, 2014, 88 (02) : 1293 - 1307
  • [29] SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    Hoffmann, Markus
    Kleine-Weber, Hannah
    Schroeder, Simon
    Krueger, Nadine
    Herrler, Tanja
    Erichsen, Sandra
    Schiergens, Tobias S.
    Herrler, Georg
    Wu, Nai-Huei
    Nitsche, Andreas
    Mueller, Marcel A.
    Drosten, Christian
    Poehlmann, Stefan
    [J]. CELL, 2020, 181 (02) : 271 - +
  • [30] COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
    Hu, Jianhua
    Zhang, Xiaoli
    Zhang, Xuan
    Zhao, Hong
    Lian, Jiangshan
    Hao, Shaorui
    Jia, Hongyu
    Yang, Meifang
    Lu, Yingfeng
    Xiang, Dairong
    Cai, Huan
    Zhang, Shanyan
    Gu, Jueqing
    Ye, Chanyuan
    Yu, Guodong
    Jin, Ciliang
    Zheng, Lin
    Yang, Yida
    Sheng, Jifang
    [J]. JOURNAL OF INFECTION, 2020, 81 (06) : 983 - 986